My NCBI | Sign In
RSS Settings
  • Search: Kuritzkes Daniel[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 133

    1.

    The Impact of The President's Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and Why It Remains Essential.

    Walensky RP, Kuritzkes DR.

    Clin Infect Dis. 2009 Nov 30. [Epub ahead of print]PMID: 19947830 [PubMed - as supplied by publisher]

    2.

    Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.

    Paredes R, Cheng I, Kuritzkes DR, Tuomala RE; for the Women and Infants Transmission Study (WITS) Group.

    AIDS. 2009 Nov 12. [Epub ahead of print]PMID: 19915448 [PubMed - as supplied by publisher]Related articles

    3.

    Rapid automated cell quantification on HIV microfluidic devices.

    Alyassin MA, Moon S, Keles HO, Manzur F, Lin RL, Hæggstrom E, Kuritzkes DR, Demirci U.

    Lab Chip. 2009 Dec 7;9(23):3364-3369. Epub 2009 Sep 30.PMID: 19904402 [PubMed - as supplied by publisher]Related articles

    4.

    Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.

    Su Z, Gulick RM, Krambrink A, Coakley E, Hughes MD, Han D, Flexner C, Wilkin TJ, Skolnik PR, Greaves WL, Kuritzkes DR, Reeves JD; AIDS Clinical Trials Group A5211 Team.

    J Infect Dis. 2009 Dec 1;200(11):1724-8.PMID: 19874179 [PubMed - in process]Related articles

    5.

    Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets.

    Assoumou L, Cozzi-Lepri A, Brun-Vézinet F, Degruttola V, Kuritzkes DR, Phillips A, Zolopa A, Miller V, Flandre P, Costagliola D; on behalf of the Standardization, Clinical Relevance of HIV Drug Resistance Testing Project from the Forum for Collaborative HIV Research.

    AIDS. 2009 Oct 27. [Epub ahead of print]PMID: 19864933 [PubMed - as supplied by publisher]Related articles

    6.

    Quantum dot-based HIV capture and imaging in a microfluidic channel.

    Kim YG, Moon S, Kuritzkes DR, Demirci U.

    Biosens Bioelectron. 2009 Sep 15;25(1):253-8. Epub 2009 Jun 18.PMID: 19665685 [PubMed - in process]Related articles

    7.

    Interleukin-2: trials and tribulations.

    Kuritzkes DR.

    J Infect Dis. 2009 Jul 15;200(2):164-5. No abstract available. PMID: 19508158 [PubMed - indexed for MEDLINE]Related articles

    8.

    Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.

    Hosoya N, Su Z, Wilkin T, Gulick RM, Flexner C, Hughes MD, Skolnik PR, Giguel F, Greaves WL, Coakley E, Kuritzkes DR.

    J Clin Microbiol. 2009 Aug;47(8):2604-6. Epub 2009 Jun 3.PMID: 19494074 [PubMed - indexed for MEDLINE]Related articles

    9.

    Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.

    Tsibris AM, Korber B, Arnaout R, Russ C, Lo CC, Leitner T, Gaschen B, Theiler J, Paredes R, Su Z, Hughes MD, Gulick RM, Greaves W, Coakley E, Flexner C, Nusbaum C, Kuritzkes DR.

    PLoS One. 2009 May 25;4(5):e5683.PMID: 19479085 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Integrating microfluidics and lensless imaging for point-of-care testing.

    Moon S, Keles HO, Ozcan A, Khademhosseini A, Haeggstrom E, Kuritzkes D, Demirci U.

    Biosens Bioelectron. 2009 Jul 15;24(11):3208-14. Epub 2009 Apr 2.PMID: 19467854 [PubMed - indexed for MEDLINE]Related articles

    11.

    HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians.

    Lubinski C, Aberg J, Bardeguez AD, Elion R, Emmanuel P, Kuritzkes D, Saag M, Squires KE, Weddle A, Rainey J, Zerehi MR, Ralston JF, Fleming DA, Bronson D, Cooke M, Cutler C, Ejnes Y, Gluckman R, Liebow M, Musana K, Mayer ME, Purtle MW, Reynolds PP, Viswanathan L, Weiss KB, Yehia B.

    Clin Infect Dis. 2009 May 15;48(10):1335-44. No abstract available. PMID: 19385087 [PubMed - indexed for MEDLINE]Related articles

    12.

    A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors.

    Moore JP, Kuritzkes DR.

    Curr Opin HIV AIDS. 2009 Mar;4(2):118-24. Review.PMID: 19339950 [PubMed - indexed for MEDLINE]Related articles

    13.

    HIV-1 entry inhibitors: an overview.

    Kuritzkes DR.

    Curr Opin HIV AIDS. 2009 Mar;4(2):82-7. Review.PMID: 19339945 [PubMed - indexed for MEDLINE]Related articles

    14.

    Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

    Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW.

    PLoS One. 2009;4(3):e4724. Epub 2009 Mar 6.PMID: 19266092 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.

    Tenorio AR, Jiang H, Zheng Y, Bastow B, Kuritzkes DR, Bartlett JA, Deeks SG, Landay AL, Riddler SA.

    AIDS Res Hum Retroviruses. 2009 Feb;25(2):135-9.PMID: 19239354 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.

    Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR.

    Clin Infect Dis. 2009 Mar 1;48(5):642-9.PMID: 19191652 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Drug Therapy in HIV Infection--Ninth International Congress.

    Kuritzkes DR.

    IDrugs. 2009 Jan;12(1):20-5. No abstract available. PMID: 19127500 [PubMed - indexed for MEDLINE]Related articles

    18.

    Update of the Drug Resistance Mutations in HIV-1.

    Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD.

    Top HIV Med. 2008 Dec;16(5):138-45. Review. Erratum in: Top HIV Med. 2009 Feb-Mar;17(1):13. PMID: 19106428 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine.

    Paredes R, Sagar M, Marconi VC, Hoh R, Martin JN, Parkin NT, Petropoulos CJ, Deeks SG, Kuritzkes DR.

    J Virol. 2009 Feb;83(4):2038-43. Epub 2008 Nov 19.PMID: 19019971 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults.

    Jacobson JM, Kuritzkes DR, Godofsky E, DeJesus E, Larson JA, Weinheimer SP, Lewis ST.

    Antimicrob Agents Chemother. 2009 Feb;53(2):450-7. Epub 2008 Nov 17.PMID: 19015347 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    21 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity